南美洲和中美洲结直肠癌诊断市场预测至 2028 年 - COVID-19 影响和区域分析 - 按方式 [成像测试(结肠镜检查、CT 结肠镜检查、柔性乙状结肠镜检查、胶囊内窥镜检查等)和粪便测试(粪便免疫化学测试( FIT)、基于愈创木脂的粪便潜血测试和粪便 DNA 测试)]和最终用户(医院、诊断实验室、癌症研究机构等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 131    |    Report Code: BMIRE00028835    |    Category: Life Sciences

South & Central America Colorectal Cancer Diagnostics Market

南部和南部2023年中美洲结直肠癌诊断市场价值为7.4913亿美元,预计到2028年将达到10.8786亿美元。预计2023年至2028年复合年增长率为7.7%。

结肠镜检查中的人工智能中美洲结直肠癌诊断市场

胃肠病学中结直肠癌 (CRC) 的早期检测为患者提供了无病生存和总体生存的最佳机会。然而,结肠镜检查结果显示病变检测存在显着差异。腺瘤检出率(ADR)是评价内镜医师结肠镜筛查结直肠癌筛查质量的金标准。

人工智能技术在多种类型诊断和治疗中的应用癌症,特别是结直肠癌的发病率现在越来越受到人们的关注。各种人工智能支持系统可用于个性化和新颖的结直肠癌治疗策略。在内窥镜检查中,人工智能广泛涉及计算机视觉技术,允许计算机“看到”内窥镜。并解释视觉内容。通过机器学习过程和深度学习,人工智能系统可以被训练来识别“正常”的事物。通过将黄金标准与合适的图像联系起来来描述特征。使用计算机视觉进行病变检测将是人工智能在胃肠病学中的首次应用。它将有助于提高结肠镜检查中发现和识别息肉的内窥镜检查实践的质量。

尽管结肠镜检查中的人工智能是一个范围广泛的新领域,但它有可能提高质量内窥镜检查和患者护理。它还可以改变结肠镜检查的管理绩效和质量改进的过程,同时改进几个关键绩效指标。美敦力 (Medtronic) 在印度推出了人工智能驱动的 GI Genius 结肠镜检查模块。这种依赖于深度学习算法和实时数据的变革性解决方案使医生能够通过在结肠镜检查过程中提供增强的可视化来检测和治疗结直肠癌。 GI Genius 等人工智能应用可以改善 ADR,促进结直肠癌的早期检测、更好的病变临床管理以及组织的详细表征。因此,采用人工智能进行结直肠癌成像测试可能会为南美地区带来新趋势。未来几年中美洲结直肠癌诊断市场。

South &中美洲结直肠癌诊断市场概况

南部和中部地区中美洲结直肠癌诊断市场分为巴西、阿根廷和南美其他地区。中美洲。据巴西卫生部称,由于农作物使用杀虫剂,结肠癌病例显着增加。食用此类食物和水会导致结肠癌的发生。此外,老年人中结直肠癌的患病率较高。根据 Globocan 2020 数据,2020 年巴西新增约 55,102 例结直肠癌病例。此外,男性病例为 27,346 例,女性病例为 27,756 例。巴西各地,特别是私营部门,开展了有关结直肠癌的宣传活动。巴西肠癌预防协会 (ABRAPRECI) 和结直肠癌预防和筛查计划已经启动。宣传活动和筛查计划的增长增加了对结肠镜检查服务的需求。此外,2020年12月,法国诊断公司HalioDx与Diagnostics da America (DASA)签署协议,在巴西分销其Immunoscore结肠癌风险评估测试。免疫评分通过测量肿瘤部位的宿主免疫反应来帮助预测早期结肠癌复发的风险,这有助于规划治疗策略。根据协议条款,位于巴西圣保罗的 DASA 拥有该测试的独家经销权,通过 40 个实验室网络提供该测试。由于上述因素,南美巴西中美洲结直肠癌诊断市场在预测期内可能会出现利润丰厚的机会。

 South &中美洲结直肠癌诊断市场收入及预测至 2028 年(百万美元)

< p>

南和南中美洲结直肠癌诊断市场细分

南部和中部地区中美洲结直肠癌诊断市场按模式、最终用户和国家/地区进行细分。中美洲结直肠癌诊断市场分为成像测试和粪便测试。 2023年,成像测试领域在南美两国占据更大份额。中美洲结直肠癌诊断市场。影像测试市场进一步细分为结肠镜检查、CT结肠造影、柔性乙状结肠镜检查、胶囊内窥镜检查等。基于粪便的测试市场细分为粪便免疫化学测试 (fit)、基于愈创木脂的粪便潜血测试 (gfobt) 和粪便 DNA 测试。

基于最终用户,南部和南部地区中美洲结直肠癌诊断市场分为医院、诊断实验室、癌症研究机构等。 2023 年,医院部门在南美和南美地区占据最大份额。中美洲结直肠癌诊断市场。

基于国家、南部和非洲地区。中美洲结直肠癌诊断市场分为巴西、阿根廷和南美其他地区。中美洲。 2023年,巴西占南美地区最大份额。中美洲结直肠癌诊断市场。

Medtronic Plc、Illumina Inc、F. Hoffmann-La Roche Ltd、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp.;和 Eiken Chemical Co., Ltd. 是在南部和南部地区运营的领先公司。中美洲结直肠癌诊断市场。



South & Central America Colorectal Cancer Diagnostics Strategic Insights

Strategic insights for South & Central America Colorectal Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-colorectal-cancer-diagnostics-market-strategic-framework.webp
Get more information on this report

South & Central America Colorectal Cancer Diagnostics Report Scope

Report Attribute Details
Market size in 2023 US$ 749.13 Million
Market Size by 2028 US$ 1,087.86 Million
Global CAGR (2023 - 2028) 7.7%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 方式
  • 影像学检查
  • 粪便检查
By 最终用户
  • 医院
  • 诊断实验室
  • 癌症研究机构
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Bruker Corp
  • Clinical
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Medtronic Plc
  • Quest Diagnostics Inc
  • Siemens Healthineers AG
  • Get more information on this report

    South & Central America Colorectal Cancer Diagnostics Regional Insights

    The regional scope of South & Central America Colorectal Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-colorectal-cancer-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Colorectal Cancer Diagnostics Market

    1. Bruker Corp                                             
    2. Clinical
    3. F. Hoffmann-La Roche Ltd                     
    4. Illumina Inc        
    5. Medtronic Plc    
    6. Quest Diagnostics Inc                          
    7. Siemens Healthineers AG                    
    Frequently Asked Questions
    How big is the South & Central America Colorectal Cancer Diagnostics Market?

    The South & Central America Colorectal Cancer Diagnostics Market is valued at US$ 749.13 Million in 2023, it is projected to reach US$ 1,087.86 Million by 2028.

    What is the CAGR for South & Central America Colorectal Cancer Diagnostics Market by (2023 - 2028)?

    As per our report South & Central America Colorectal Cancer Diagnostics Market, the market size is valued at US$ 749.13 Million in 2023, projecting it to reach US$ 1,087.86 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.

    What segments are covered in this report?

    The South & Central America Colorectal Cancer Diagnostics Market report typically cover these key segments-

  • 方式 (影像学检查, 粪便检查)
  • 最终用户 (医院, 诊断实验室, 癌症研究机构)
  • What is the historic period, base year, and forecast period taken for South & Central America Colorectal Cancer Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Colorectal Cancer Diagnostics Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in South & Central America Colorectal Cancer Diagnostics Market?

    The South & Central America Colorectal Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bruker Corp
  • Clinical
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Medtronic Plc
  • Quest Diagnostics Inc
  • Siemens Healthineers AG
  • Who should buy this report?

    The South & Central America Colorectal Cancer Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Colorectal Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.